Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation

NCT03836833 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: ABC/3TC/LPV/r granules (30/15/40/10 mgs)
DRUG: LPV/r Pellets (40/10mgs) plus ABC/3TC (60/30mgs)

Sponsor

Drugs for Neglected Diseases

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]